Concepedia

Sherry L. Nelson

SL

Statistics

Publications

6

Citations

354

H-Index

6

Active since

1996

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

New Mexico State University

Sherry L. Nelson is an author at Abbott Fund specializing in neuropharmacology, medicinal chemistry, and pharmacology.

Publications per year

1996–2006

6

Publications

6

Rhenium-Catalyzed Oxidation of Thiols and Disulfides with Sulfoxides

Jeffrey B. Arterburn, Marc C. Perry, Sherry L. Nelson et al. · Journal of the American Chemical Society · 1997 · 123 citations

, , +12

Discovery of 2-(4-Pyridin-2-ylpiperazin-1-ylmethyl)-1 <i>H</i> -benzimidazole (ABT-724), a Dopaminergic Agent with a Novel Mode of Action for the Potential Treatment of Erectile Dysfunction

Marlon Cowart, Steven P. Latshaw, Pramila Bhatia et al. · Journal of Medicinal Chemistry · 2004 · 61 citations · Full text

, , +17

Rhenium-Catalyzed Oxidation of Sulfides with Phenyl Sulfoxide

Jeffrey B. Arterburn, Sherry L. Nelson · The Journal of Organic Chemistry · 1996 · 59 citations

, , +10

Discovery of 3-Methyl-<i>N</i>-(1-oxy-3‘,4‘,5‘,6‘-tetrahydro-2‘<i>H</i>-[2,4‘-bipyridine]-1‘-ylmethyl)benzamide (ABT-670), an Orally Bioavailable Dopamine D<sub>4</sub> Agonist for the Treatment of Erectile Dysfunction

Meena Patel, Teodozyj Kolasa, Kathleen H. Mortell et al. · Journal of Medicinal Chemistry · 2006 · 43 citations · Full text

, , +17

Dopamine D<sub>4</sub>Ligands and Models of Receptor Activation:  2-(4-Pyridin-2-ylpiperazin-1-ylmethyl)-1<i>H</i>-benzimidazole and Related Heteroarylmethylarylpiperazines Exhibit a Substituent Effect Responsible for Additional Efficacy Tuning

Andrew O. Stewart, Marlon Cowart, Robert B. Moreland et al. · Journal of Medicinal Chemistry · 2004 · 38 citations · Full text

, , +17

1–5 of 6